{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:49:37Z","timestamp":1785872977342,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.amjms.2026.03.008","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:26:08Z","timestamp":1773645968000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B virus exposure and metabolic dysfunction-associated steatotic liver disease in U.S. adults: A nationally representative analysis from NHANES 2017-2020"],"prefix":"10.1016","volume":"372","author":[{"given":"Youping","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2026.03.008_bib0001","doi-asserted-by":"crossref","DOI":"10.4103\/sjg.sjg_62_24","article-title":"The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in saudi arabia","author":"Alqahtani","year":"2024","journal-title":"Saudi J Gastroenterol: Off J Saudi Gastroenterol Assoc"},{"issue":"6","key":"10.1016\/j.amjms.2026.03.008_bib0002","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1473-3099(24)00307-4","article-title":"WHO\u2019s 2024 global hepatitis report","volume":"24","author":"Burki","year":"2024","journal-title":"Lancet, Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2026.03.008_bib0003","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.amjms.2026.03.008_bib0004","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc."},{"issue":"2","key":"10.1016\/j.amjms.2026.03.008_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/apt.17846","article-title":"Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Loomba","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.amjms.2026.03.008_bib0006","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0007","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-023-10620-y","article-title":"Breaking new ground: MASLD vs. MAFLD\u2014which holds the key for risk stratification?","volume":"18","author":"Ram\u00edrez-Mej\u00eda","year":"2024","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.amjms.2026.03.008_bib0008","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.amjms.2026.03.008_bib0009","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1128\/JVI.02604-15","article-title":"Hepatitis B virus X protein induces hepatic steatosis by enhancing the expression of liver fatty acid binding protein","volume":"90","author":"Wu","year":"2016","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.amjms.2026.03.008_bib0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/liv.14369","article-title":"Chronic hepatitis B and non-alcoholic fatty liver disease: conspirators or competitors?","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.amjms.2026.03.008_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.965548","article-title":"NAFLD and HBV interplay - related mechanisms underlying liver disease progression","volume":"13","author":"Tourkochristou","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0012","first-page":"68","article-title":"Metabolic dysfunction-associated fatty liver disease and chronic viral hepatitis: the interlink","volume":"13","author":"Fernandez","year":"2024","journal-title":"Pathog (Basel Switz)"},{"issue":"3","key":"10.1016\/j.amjms.2026.03.008_bib0013","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.28917","article-title":"Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study","volume":"65","author":"Joo","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2026.03.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.13979","article-title":"Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease","author":"Patel","year":"2024","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0015","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/s41598-020-62609-4","article-title":"Association between hepatitis B virus infection and metabolic syndrome in southwest China: a cross-sectional study","volume":"10","author":"Yan","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12985-023-02277-8","article-title":"Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study","volume":"21","author":"Yi","year":"2024","journal-title":"Virol J"},{"issue":"5","key":"10.1016\/j.amjms.2026.03.008_bib0017","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/hep.32792","article-title":"HBV-related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta-analysis","volume":"77","author":"Mao","year":"2023","journal-title":"Hepatol (Baltim Md,)"},{"issue":"6","key":"10.1016\/j.amjms.2026.03.008_bib0018","doi-asserted-by":"crossref","first-page":"867","DOI":"10.14309\/ajg.0000000000000588","article-title":"Positive hepatitis B core antibody is associated with cirrhosis and hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"115","author":"Chan","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0019","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41598-023-28351-3","article-title":"Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection","volume":"13","author":"Lv","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2026.03.008_bib0020","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2147\/DMSO.S369824","article-title":"Association between metabolic dysfunction-associated fatty liver disease and the risk of cirrhosis in patients with chronic hepatitis B\u2014a retrospective cohort study","volume":"15","author":"Wang","year":"2022","journal-title":"Diabetes Metab Syndr Obes: Targets Ther"},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0021","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/s12903-024-04489-y","article-title":"Hepatitis B infection is associated with periodontitis: the national health and nutrition examination survey (2009-2014)","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.amjms.2026.03.008_bib0022","unstructured":"NHANES survey methods and analytic guidelines. Accessed November 12, 2024. NHANES Survey Methods and Analytic Guidelines."},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0023","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.amjms.2026.03.008_bib0024","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.jhep.2023.08.019","article-title":"Prevalence of steatotic liver disease and associated fibrosis in the United States: results from NHANES 2017-March 2020","volume":"80","author":"Luo","year":"2024","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1016\/j.amjms.2026.03.008_bib0025","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/cid\/ciz669","article-title":"Prevalence of hepatitis B virus infection among US adults aged 20-59 years with a history of injection drug use: national health and nutrition examination survey, 2001-2016","volume":"70","author":"Shing","year":"2020","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"21","key":"10.1016\/j.amjms.2026.03.008_bib0026","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.3390\/nu14214505","article-title":"Dietary quality and relationships with metabolic dysfunction-associated fatty liver disease (MAFLD) among united states adults, results from NHANES 2017-2018","volume":"14","author":"Tian","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.amjms.2026.03.008_bib0027","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jvh.13862","article-title":"Impact of prior HBV, HAV, and HEV infection on non-alcoholic fatty liver disease","volume":"30","author":"Vassilopoulos","year":"2023","journal-title":"J Viral Hepatitis"},{"issue":"4","key":"10.1016\/j.amjms.2026.03.008_bib0028","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s10620-024-08354-4","article-title":"Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B","volume":"69","author":"Con","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.amjms.2026.03.008_bib0029","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12985-023-02277-8","article-title":"Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study","volume":"21","author":"Yi","year":"2024","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.amjms.2026.03.008_bib0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cgh.2023.09.040","article-title":"Metabolic dysfunction-associated steatotic liver disease facilitates hepatitis B surface antigen seroclearance and seroconversion","volume":"22","author":"Huang","year":"2024","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.amjms.2026.03.008_bib0031","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2147\/CMAR.S368366","article-title":"Impact of metabolic dysfunction associated fatty liver disease on the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma based on propensity score matching analysis","volume":"14","author":"Xue","year":"2022","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.amjms.2026.03.008_bib0032","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3350\/cmh.2022.0422","article-title":"Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: challenges and perspectives","volume":"29","author":"Huang","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.amjms.2026.03.008_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.965548","article-title":"NAFLD and HBV interplay - related mechanisms underlying liver disease progression","volume":"13","author":"Tourkochristou","year":"2022","journal-title":"Front Immunol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:41:02Z","timestamp":1785872462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962926001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0002962926001114"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2026.03.008","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus exposure and metabolic dysfunction-associated steatotic liver disease in U.S. adults: A nationally representative analysis from NHANES 2017-2020","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2026.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}